| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
15,090,000 |
| Market
Cap: |
3.80(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.242 - $6.17 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Ampio Pharmaceuticals is a biopharmaceutical company focused on the research, development and improvement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Ampion, Co.'s primary product candidate is a biologic drug, which contains ingredients that target several pathways in the innate immune response characteristic of inflammatory disease. Ampion is in development as an intra-articular injection treatment for severe Osteoarthritis of the Knee; an intravenous and inhaled treatment for COVID-19 patients; and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
318,748 |
318,748 |
| Total Buy Value |
$0 |
$0 |
$81,874 |
$81,874 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
8 |
8 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Buchi J Kevin |
Director |
– • – |
2023-06-09 |
4 |
B |
$0.29 |
$6,284 |
D/D |
21,858 |
146,858 |
2.39 |
-46% |
|
| Buchi J Kevin |
Director |
– • – |
2023-06-08 |
4 |
B |
$0.30 |
$7,400 |
D/D |
25,000 |
125,000 |
2.39 |
-42% |
|
| Martino Michael A |
CEO |
• • – |
2023-05-24 |
4 |
B |
$0.29 |
$22,121 |
D/D |
76,890 |
76,890 |
2.81 |
-39% |
|
| Buchi J Kevin |
Director |
– • – |
2023-05-16 |
4 |
B |
$0.27 |
$8,924 |
D/D |
32,534 |
100,000 |
2.39 |
-33% |
|
| Buchi J Kevin |
Director |
– • – |
2023-05-15 |
4 |
B |
$0.25 |
$10,857 |
D/D |
44,026 |
67,466 |
2.39 |
-21% |
|
| Buchi J Kevin |
Director |
– • – |
2023-05-12 |
4 |
B |
$0.24 |
$5,513 |
D/D |
23,440 |
23,440 |
2.39 |
-11% |
|
| Stevens David R |
Director |
– • – |
2023-05-12 |
4 |
B |
$0.22 |
$9,900 |
D/D |
45,000 |
103,971 |
2.39 |
-11% |
|
| Stevens David R |
Director |
– • – |
2023-05-11 |
4 |
B |
$0.22 |
$10,875 |
D/D |
50,000 |
58,971 |
2.39 |
-17% |
|
| Macaluso Michael |
|
– • – |
2022-01-01 |
4 |
D |
$0.57 |
$38,988 |
D/D |
(68,400) |
2,624,882 |
|
- |
|
| Stokely Dan |
CFO |
• – – |
2022-01-01 |
4 |
D |
$0.57 |
$13,061 |
D/D |
(22,914) |
312,274 |
|
- |
|
| Cherevka Holli |
PRESIDENT AND COO |
• – – |
2022-01-01 |
4 |
D |
$0.57 |
$26,904 |
D/D |
(47,200) |
410,820 |
|
- |
|
| Stokely Dan |
CFO |
• – – |
2021-10-27 |
4 |
D |
$1.64 |
$46,128 |
D/D |
(28,127) |
335,188 |
|
- |
|
| Macaluso Michael |
CEO |
• • – |
2021-10-27 |
4 |
D |
$1.64 |
$71,291 |
D/D |
(43,470) |
2,693,282 |
|
- |
|
| Cherevka Holli |
PRESIDENT AND COO |
• – – |
2021-10-27 |
4 |
D |
$1.64 |
$68,847 |
D/D |
(41,980) |
458,020 |
|
- |
|
| Stokely Dan |
CFO |
• – – |
2021-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
335,000 |
363,315 |
|
- |
|
| Macaluso Michael |
CEO |
• • – |
2021-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
950,000 |
2,736,752 |
|
- |
|
| Cherevka Holli |
CHIEF OPERATING OFFICER |
• – – |
2021-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
500,000 |
|
- |
|
| Stokely Dan |
CFO |
• – – |
2021-06-25 |
4 |
S |
$1.79 |
$40,275 |
D/D |
(22,500) |
28,315 |
|
10% |
|
| Stokely Dan |
CFO |
• – – |
2021-06-25 |
4 |
OE |
$0.43 |
$9,675 |
D/D |
22,500 |
50,815 |
|
- |
|
| Cherevka Holli |
CHIEF OPERATING OFFICER |
• – – |
2021-05-21 |
4 |
AS |
$2.00 |
$5,206 |
D/D |
(2,603) |
0 |
|
-15% |
|
| Cherevka Holli |
CHIEF OPERATING OFFICER |
• – – |
2021-05-21 |
4 |
OE |
$0.51 |
$1,328 |
D/D |
2,603 |
2,603 |
|
- |
|
| Coelho Philip H |
|
– • – |
2021-05-21 |
4 |
AS |
$2.00 |
$13,474 |
D/D |
(6,737) |
203,500 |
|
-15% |
|
| Coelho Philip H |
|
– • – |
2021-05-21 |
4 |
OE |
$0.40 |
$2,695 |
D/D |
6,737 |
210,237 |
|
- |
|
| Stokely Dan |
CFO |
• – – |
2021-05-18 |
4 |
S |
$1.83 |
$63,980 |
D/D |
(35,000) |
28,315 |
|
4% |
|
| Stokely Dan |
CFO |
• – – |
2021-05-17 |
4 |
OE |
$0.43 |
$15,050 |
D/D |
35,000 |
63,315 |
|
- |
|
93 Records found
|
|
Page 1 of 4 |
|
|
0.08 (23.64%) 
